Elbit Imaging Ltd

Loading quotes...

Forecast

There is no analyst data available for this company.

News Go to news feed

There is currently no news available for this company. We are working on adding more providers to change this.

Historical dividends Dividends

All dividend metrics All metrics

In 2023, Elbit Imaging Ltd has already paid €0.0363 in dividends. The last payout was in July 2023.

Financials

In the last quarter, Elbit Imaging Ltd had revenue of €4.72M and net profit of -€511.07K

(EUR)	March 2026	YoY
Revenue	4.72M	-
Gross profit	1.38M	-
Net profit	-511.07K	-
EBITDA	173.8K	-

Fundamentals

Metric	Value
Market capitalization	€18.96M
Number of shares	13.28M
52-week high/low	€1.92 - €0.0446
Dividends	No
Beta	0.30
P/E ratio	-12.27
PEG ratio	0.05
P/B ratio	0.96
P/S ratio	0.00

Company profile

Elbit Imaging Ltd., together with its subsidiaries, engages in the development, production, and marketing of therapeutic medical systems for performing non-invasive treatments on the human body in the North and South America, Europe, Asia, and Oceania. The company offers treatment-oriented medical systems with ultrasound beam and magnetic resonance imaging for noninvasive treatments in human body. It also offers medical products based on stem cells derived primarily from umbilical cord blood and intended for bone marrow transplantation in patients with leukemia or lymph node cancer, non-malignant blood diseases, and metabolic genetic diseases. In addition, the company is involved in the sale of plots and villas in India. The company was incorporated in 1996 and is headquartered in Petach Tikva, Israel.

Name	Elbit Imaging Ltd
CEO	Ron Hadassi
Headquarters	Bnei Brak, wa Israel
Website	elbitimaging.com
Sector	Industrials
Industry	Construction & Engineering
IPO	06/06/2018
Employees	20